Top Story

Gilead Sciences receives CHMP positive opinion for DAA Vosevi

June 23, 2017

Gilead Sciences announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion on the company’s Marketing Authorization Application for its direct-acting antiviral regimen sofosbuvir-velpatasvir-voxilaprevir, or Vosevi, according to a press release.

The application for Vosevi includes data from four phase 3 studies that support its safe use in patients with hepatitis C genotypes 1 through 6, with or without compensated cirrhosis, regardless of prior therapy. The recommended regimens are 8 weeks of treatment in DAA-naive patients and 12 weeks for those who have previously failed DAA therapy.

In the Journals

Interferon-based SVR in HCV reduced risk for extrahepatic manifestations

June 23, 2017
Sustained virologic response following interferon-based antiviral therapy in patients with hepatitis C reduced the risk for extrahepatic manifestations, according to…

Five French patients infected with hepatitis E strain found in rabbits

June 22, 2017
In a rare finding, researchers in France discovered five cases of human infection with a hepatitis E virus strain found in rabbits. The researchers said they could not…

Senate health care bill takes slower approach to House bill, expert concerns persist

June 22, 2017
The Senate health care bill, released to the public today, maintains much from the version the House passed May 4, 2017, but presents some key changes such as a slower…

No science needed to blame vaccines for illness, EU court rules

June 22, 2017
The European Union Court of Justice has ruled that illnesses can be attributed to vaccines during litigation without scientific proof. The judges decided that factors
More News Headlines »

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »
GI Bookshelf

Chapter 6: Nutrients To Nourish The Organisms: Prebiotics And Fiber

From Probiotics: A Clinical Guide
More »
International Liver Congress

International Liver Congress

Video Perspective

VIDEO: AHCA still faces 'uphill battle' in Senate, speaker says

May 4, 2017
More »
Current Issues Current Issues
View the Current Issue
HCV Next